Baker Biotech Fund II (A), L.P.
Insider CIK 1551130 · GEVA Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GEVA SYNAGEVA BIOPHARMA CORP | J Other | 2015-06-22 | 2015-06-22 | 211,614 | — | $0 | 12,250 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | J Other | 2015-06-22 | 2015-06-22 | 21,196 | — | $0 | 100,523 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | J Other | 2015-06-22 | 2015-06-22 | 206,800 | — | $0 | 12,250 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | J Other | 2015-06-22 | 2015-06-22 | 19,318 | — | $0 | 20,338 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | J Other | 2015-06-22 | 2015-06-22 | 165,213 | — | $0 | 12,250 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | J Other | 2015-06-22 | 2015-06-22 | 12,500 | — | $0 | 32,838 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | J Other | 2015-06-22 | 2015-06-22 | 55,479 | — | $0 | 12,250 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | J Other | 2015-06-22 | 2015-06-22 | 5,543 | — | $0 | 38,381 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | J Other | 2015-06-22 | 2015-06-22 | 1,068,128 | — | $0 | 680,187 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | J Other | 2015-06-22 | 2015-06-22 | 100,490 | — | $0 | 12,250 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | J Other | 2015-06-22 | 2015-06-22 | 497 | — | $0 | 79,327 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | J Other | 2015-06-22 | 2015-06-22 | 40,449 | — | $0 | 78,830 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-06-20 | 2014-06-24 | 4,250 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-06-20 | 2014-06-24 | 4,250 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-06-20 | 2014-06-24 | 4,250 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-06-20 | 2014-06-24 | 4,250 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-06-20 | 2014-06-24 | 4,250 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-06-20 | 2014-06-24 | 4,250 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-06-20 | 2014-06-24 | 4,250 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-06-20 | 2014-06-24 | 4,250 | $60.45 | $256.9K | 177,463 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-06-20 | 2014-06-24 | 4,250 | $60.45 | $256.9K | 219,050 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-06-20 | 2014-06-24 | 4,250 | $60.45 | $256.9K | 223,864 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-06-20 | 2014-06-24 | 4,250 | $60.45 | $256.9K | 8,184,771 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-06-20 | 2014-06-24 | 4,250 | $60.45 | $256.9K | 112,740 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-06-20 | 2014-06-24 | 4,250 | $60.45 | $256.9K | 1,748,315 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-06-20 | 2014-06-24 | 4,250 | $60.45 | $256.9K | 67,729 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2014-06-04 | 2014-06-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-04-23 | 2014-04-25 | 8,000 | $65.10 | $520.8K | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-04-23 | 2014-04-25 | 8,000 | $65.10 | $520.8K | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-04-23 | 2014-04-25 | 8,000 | $65.10 | $520.8K | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-04-23 | 2014-04-25 | 8,000 | $65.10 | $520.8K | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-04-23 | 2014-04-25 | 8,000 | $65.10 | $520.8K | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-04-23 | 2014-04-25 | 8,000 | $65.10 | $520.8K | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise deriv | 2014-04-23 | 2014-04-25 | 8,000 | $65.10 | $520.8K | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-04-23 | 2014-04-25 | 8,000 | $65.10 | $520.8K | 8,180,521 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-04-23 | 2014-04-25 | 8,000 | $65.10 | $520.8K | 63,479 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-04-23 | 2014-04-25 | 8,000 | $65.10 | $520.8K | 173,213 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-04-23 | 2014-04-25 | 8,000 | $65.10 | $520.8K | 219,614 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-04-23 | 2014-04-25 | 8,000 | $65.10 | $520.8K | 1,744,065 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-04-23 | 2014-04-25 | 8,000 | $65.10 | $520.8K | 108,490 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | M Exercise | 2014-04-23 | 2014-04-25 | 8,000 | $65.10 | $520.8K | 214,800 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2013-06-06 | 2013-06-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2013-06-06 | 2013-06-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2013-06-06 | 2013-06-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2013-06-06 | 2013-06-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2013-06-06 | 2013-06-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2013-06-06 | 2013-06-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2013-06-06 | 2013-06-10 | 15,000 | — | $0 | 15,000 | SEC↗ |